Physician
Larchmont Family Medicine, PLLC
Larchmont Family Medicine, PLLC was paid $321K by Medicaid between Dec 2018 and Dec 2024, across 19 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 45% of everything it billed.
33Billing provider infoLARCHMONT FAMILY MEDICINE, PLLC
LARCHMONT, NY 10538
LARCHMONT, NY 10538
33aNPI1124487087assigned 02/19/2016
33bProvider typeFamily Medicine Physician
28Total paid$321K
24GClaims4,829
24DCodes billed19
24AFirst – last monthDec 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in New York
Rank by total paid#298 of 2,605
Median peer was paid$10K
This provider vs. median32×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 30 | $2K | |
| 2019 | 115 | $8K | |
| 2020 | 290 | $13K | |
| 2021 | 986 | $48K | |
| 2022 | 1,135 | $87K | |
| 2023 | 1,157 | $106K | |
| 2024incomplete | 1,116 | $57K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 45% | 1,931 | 1,655 | $145K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 35% | 962 | 327 | $112K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.6% | 206 | 189 | $21K |
| 99442 | 3.0% | 142 | 130 | $10K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.8% | 276 | 146 | $9K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.8% | 140 | 91 | $9K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.1% | 173 | 117 | $4K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 29 | 27 | $3K |
| 0012A | <1% | 56 | 56 | $2K | |
| 0011A | <1% | 56 | 56 | $2K | |
| 0013A | <1% | 39 | 39 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 438 | 422 | $1K |
7 more codes
| 90686 | <1% | 39 | $617.26 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 30 | $599.47 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 41 | $353.59 |
| 96127 | <1% | 43 | $174.22 | |
| 81002 | <1% | 62 | $131.24 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 13 | $58.28 |
| 91301 | 0% | 153 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHEINEGG, PHILIP (OWNER)